Genome-resolved metagenomics reveals population-dependent gut microbiome responses to albendazole-ivermectin treatment

Soil-transmitted helminth control relies on mass anthelmintic treatment, yet helminth-anthelmintic-microbiome interactions and their role on treatment response remain poorly understood. We characterised the microbiome, resistome, and functional profiles of 858 paired stool metagenomes from 429 children treated with albendazole or a fixed-dose albendazole-ivermectin co-formulation in the ALIVE clinical trial in Ethiopia and Mozambique. Baseline microbiome composition differed more by country than infection status and was not associated with albendazole efficacy or adverse events. Co-formulation treatment, particularly three consecutive daily doses, was associated with depletion of Enterobacteriaceae, predominantly Escherichia coli, in Ethiopia, with reductions in E. coli-associated resistance genes and metabolic pathways. Genome-resolved analyses of over 22,000 high-quality metagenome-assembled genomes confirmed this depletion across multiple E. coli strain-level populations, linking taxonomic, resistome, and functional signals to one ecological event. These findings reveal an off-target effect of combination anthelmintic treatment relevant to large-scale deworming programmes and expand genomic resources for African gut microbiota.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.10.26367728
Primary Topic
Gut microbiota and health
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Genome-resolved metagenomics reveals population-dependent gut microbiome responses to albendazole-ivermectin treatment

Wendemagegn Enbiale, Stephen R. Doyle, Pedro Fleitas, Augusto Messa et al.
2 links
medRxiv
Gut microbiota and health
preprint

Genome-resolved metagenomics reveals population-dependent gut microbiome responses to albendazole-ivermectin treatment

Wendemagegn Enbiale, Stephen R. Doyle, Pedro Fleitas, Augusto Messa, Inácio Mandomando, Yan Shao, Dawit Degarege, Trevor D. Lawley, Alejandro Javier Krolewiecki, Woyneshet Gelaye, Javier Gandasegui, Áuria de Jesus, Nicole Sevilleno, Valdemiro Novela, Kirsty Ambridge, Dereje Bedane, Terry K. Judah, Jose Muñoz, Joana Dias, Anna Bewsher
preprint en

Abstract

Soil-transmitted helminth control relies on mass anthelmintic treatment, yet helminth-anthelmintic-microbiome interactions and their role on treatment response remain poorly understood. We characterised the microbiome, resistome, and functional profiles of 858 paired stool metagenomes from 429 children treated with albendazole or a fixed-dose albendazole-ivermectin co-formulation in the ALIVE clinical trial in Ethiopia and Mozambique. Baseline microbiome composition differed more by country than infection status and was not associated with albendazole efficacy or adverse events. Co-formulation treatment, particularly three consecutive daily doses, was associated with depletion of Enterobacteriaceae, predominantly Escherichia coli, in Ethiopia, with reductions in E. coli-associated resistance genes and metabolic pathways. Genome-resolved analyses of over 22,000 high-quality metagenome-assembled genomes confirmed this depletion across multiple E. coli strain-level populations, linking taxonomic, resistome, and functional signals to one ecological event. These findings reveal an off-target effect of combination anthelmintic treatment relevant to large-scale deworming programmes and expand genomic resources for African gut microbiota.

medRxiv
National University of Salta (AR), Consejo Nacional de Investigaciones Científicas y Técnicas (AR), Wellcome Sanger Institute (GB), Manhiça Health Research Centre (MZ), Barcelona Institute for Global Health (ES), Bahir Dar University (ET)
Wellcome Trust, UK Research and Innovation, European Commission, Consejo Nacional de Investigaciones Científicas y Técnicas, Universidade Nova de Lisboa, Universidad Nacional de Salta, Fundación Mundo Sano, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, European and Developing Countries Clinical Trials Partnership
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon